Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease

Movement Disorders(2020)10.1002/mds.28202Source: DataRank Database

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease is a research paper published in Movement Disorders (2020). On theSindex it has a DataRank of 0. It has been cited 125 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access125 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.54)OA: hybridTopics (30)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Ernest W. Wang ORCID,Mechelle M. Lewis ORCID,Stanisław Krzyżanowski ORCID,Colt Capan ORCID,Amanda R. Burmeister ORCID

Live enrichment

PubMed:32710594 PMC:PMC7754343 OpenAlex:https://openalex.org/W3044950861

NIEHS NIH HHS

Grant: F30 ES030607

NINDS NIH HHS

Grant: U01 NS112008

NIEHS NIH HHS

Grant: R01 ES019672

NINDS NIH HHS

Grant: U01 NS082151

FWCI

3.54

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28202

publisherhttps://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28202

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.28202

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28202

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/mds.28202

Fields of Study

Tryptophan and brain disordersParkinson's Disease Mechanisms and TreatmentsPharmacological Receptor Mechanisms and Effects

MeSH Terms

HumansKynurenineParkinson DiseaseSubstantia NigraTryptophanBiomarkers

Keywords

Quinolinic acidKynurenineKynurenine pathwayKynurenic acidSubstantia nigraCerebrospinal fluidParkinson's diseaseMetaboliteInternal medicineMedicineCentral nervous system diseaseNeuroprotectionEndocrinologyPathologyDiseaseChemistryTryptophanBiochemistryGlutamate receptorInflammationKynurenine Metabolites

Sustainable Development Goals

SDG 0: Good health and well-being